News Author: Caleb Rans Publish date: January 4, 2019
According to a quantitative imaging and molecular analysis of 63 patients with glioblastoma, women appear to fare better than men with standard-of-...
News Author: Caleb Rans Publish date: January 4, 2019
Chemotherapy for solid tumors is associated with an increased risk of therapy-related myelodysplastic syndromes or acute myeloid leukemia (tMDS/AML), ...
News Author: Caleb Rans Publish date: January 3, 2019
Most tMDS/AML cases expected to occur within the next 5 years will be attributable to chemotherapy, the researchers reported.
News Author: Caleb Rans Publish date: January 2, 2019
Results come from the largest multicenter cohort study in these patients.
News Author: Caleb Rans Publish date: January 1, 2019
Thiopurines can reduce steroid use and increase anti–tumor necrosis factor blood values.
News Author: Caleb Rans Publish date: January 1, 2019
Uptake and training in the United States have been slow, although the technique is recommended as safe and cost effective.
News Author: Caleb Rans Publish date: December 13, 2018
Screening patients with cirrhosis for hepatocellular carcinoma is an underutilized early cancer–detection technique.
News Author: Caleb Rans Publish date: December 10, 2018
Rumors of statins’ adverse side effects are greatly exaggerated.
News Author: Caleb Rans Publish date: November 26, 2018
Surrogate measures of lung disease progression may help to determine the need for early intervention.
News Author: Caleb Rans Publish date: November 16, 2018
Post esophagojejunostomy in rats, a wound repair process produces metaplastic columnar-lined esophagus likely independent of progenitor cell reprog...
News Author: Caleb Rans Publish date: November 16, 2018
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
News Author: Caleb Rans Publish date: October 25, 2018
The survival benefits are promising with the addition of bortezomib, but there was no significant difference among high-risk patients.
News Author: Caleb Rans Publish date: October 25, 2018
Final results of a phase 3 trial suggest bortezomib plus rituximab and chemotherapy can significantly improve overall survival (OS) in transplant-i...
News Author: Caleb Rans Publish date: October 24, 2018
Using preclinical models, investigators found that when common topical agents were applied at a thickness of less than 2 mm, negligible effects on ...
News Author: Caleb Rans Publish date: October 16, 2018
Renal dysfunction at therapy initiation may not alter the efficacy and safety of pazopanib, with the exception of more frequent reductions in dose....
